Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Diane Lauren Reidy
Multicenter Phase II Trial of Temsirolimus (TEM) and Bevacizumab (BEV) in Pancreatic Neuroendocrine Tumor (PNET).
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- Or Panitumumab-Refractory Metastatic Colorectal Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
From Parenchymal Preservation to Multiorgan Resection in Pancreatic Neuroendocrine Tumors (pNET), a Tailored Resection Based in Tumor Biology
HPB
Hepatology
Gastroenterology
Could Radical Antegrade Modular Pancreatosplenectomy (RAMPS) Be Indicated in Pancreatic Neuroendocrine Tumors (pNET)?
HPB
Hepatology
Gastroenterology
Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Gastric Gastrointestinal Stromal Tumor and Neuroendocrine Pancreatic Tumor: Always Neurofibromatosis?
Endoscopic Ultrasound
Hepatology
Nuclear Medicine
Radiology
Imaging
Gastroenterology
A Randomised Phase II Trial of Selumetinib vs Selumetinib Plus Temsirolimus for Soft-Tissue Sarcomas
British Journal of Cancer
Cancer Research
Oncology
Phase I Clinical Trial of Temsirolimus and Perifosine for Recurrent Glioblastoma
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
Bevacizumab Combined With Gemcitabine and Capecitabine for Advanced Pancreatic Cancer: A Phase II Study
British Journal of Cancer
Cancer Research
Oncology
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM)
Oncologist
Cancer Research
Medicine
Oncology
Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study
Investigational New Drugs
Oncology
Pharmacology
